quilizumab (106)

	

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

EVQLVESGGG LVQPGGSLRL SCAASGFTFS DYGIAWVRQA PGKGLEWVAF  50

ISDLAYTIYY ADTVTGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARDN 100

WDAMDYWGQG TLVTVSSAST KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF 150

PEPVTVSWNS GALTSGVHTF PAVLQSSGLY SLSSVVTVPS SSLGTQTYIC 200

NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV FLFPPKPKDT 250

LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY 300

RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT 350

LPPSREEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS 400

DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK    447

Light chain / Chaone lygire / Cadena ligera

DIQMTQSPSS LSASVGDRVT ITCRSSQSLV HNNANTYLHW YQQKPGKAPK  50

LLIYKVSNRF SGVPSRFSGS GSGTDFTLTI SSLQPEDFAT YYCSQNTLVP 100

WTFGQGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK 150

VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE 200

VTHQGLSSPV TKSFNRGEC                                   219

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	144-200	261-321	367-425

	22??-96??	144??-200??	261??-321??	367??-425??

Intra-L	23?-93?	139?-199?



	23???-93???	139???-199???



Inter-H-L	220-219?	220??-219???



Inter-H-H	226-226??	229-229??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

297, 297?? (non-fucosylated oligosaccharides)

	

WHO 

International Nonproprietary Names Programme	

9541

15/01/2012

		

